Files

Download

Download Full Text (744 KB)

Document Type

Poster

Description

• The purpose of this study is to explore the role of gut microbiome alterations in the treatment of anxiety and depression. • There are multiple pathological pathways that lead to the development of anxiety and depression. • Research shows a link between pathologic bacteria and low grade inflammation. This causes a disruption of neurotransmitters that are current targets of pharmacological treatment of depression and anxiety. • Transfer of “pathogenic” bacteria caused increased symptoms of anxiety and depression. • Treatment with probiotics and “protective” bacteria showed decreased BDI scores and improved symptoms. • Studies were small but show need for further research

Department

Physician Assistant Studies

Date of Work

2020

Publication Date

2020

Keywords

Gut Microbiome, anxiety, depression, Pathogenic Bacteria, mood disorders, chronic stress

Disciplines

Medicine and Health Sciences

The Gut-Brain Axis: Treating Depression Through Microbiome Alterations

Share

COinS